Antibacterial activity and increased freeze-drying stability of sialyllactose-reduced silver nanoparticles using sucrose and trehalose

Journal of Nanoscience and Nanotechnology

Volumn 12, Issue 5, 2012, Pages 3884-3895

  Noh, Hwa Jung ^a   Im, A Rang ^b   Kim, Hyun Seok ^b   Sohng, Jae Kyung ^c   Kim, Chong Kook ^a   Kim, Yeong Shik ^b   Cho, Seonho ^b   Park, Youmie ^a,b  

^a Inje University   (South Korea)

^b Seoul National University   (South Korea)

^c SunMoon University   (South Korea)

Author keywords

Antibacterial Activity; Freeze Drying; Sialyllactose; Silver Nanoparticles; Sucrose; Trehalose

Indexed keywords

ANTI-BACTERIAL ACTIVITY; FREEZE-DRYING; SIALYLLACTOSE; SILVER NANOPARTICLES; TREHALOSE;

AMIDES; ATOMIC FORCE MICROSCOPY; BIOCOMPATIBILITY; CARBOHYDRATES; CARBOXYLIC ACIDS; ESCHERICHIA COLI; LOW TEMPERATURE DRYING; NANOPARTICLES; SALMONELLA; STABILITY; SUGAR (SUCROSE); THERMOGRAVIMETRIC ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; VIRUSES;

SILVER;

ANTIINFECTIVE AGENT; BIOMATERIAL; DRUG DERIVATIVE; EXCIPIENT; LACTOSE; METAL NANOPARTICLE; SIALIC ACID DERIVATIVE; SILVER; SUCROSE; TREHALOSE;

ARTICLE; CARBOHYDRATE ANALYSIS; CHEMISTRY; DRUG EFFECT; DRUG STABILITY; ESCHERICHIA COLI; FREEZE DRYING; METHODOLOGY; MOLECULAR GENETICS; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHIMURIUM;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BIOCOMPATIBLE MATERIALS; CARBOHYDRATE SEQUENCE; DRUG STABILITY; ESCHERICHIA COLI; EXCIPIENTS; FREEZE DRYING; LACTOSE; METAL NANOPARTICLES; MOLECULAR SEQUENCE DATA; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHIMURIUM; SIALIC ACIDS; SILVER; SUCROSE; TREHALOSE;

EID: 84863971606     PISSN: 15334880     EISSN: 15334899     Source Type: Journal    
DOI: 10.1166/jnn.2012.6169     Document Type: Conference Paper

References (33)

1. V. Edwards-Jones, Lett. Appl. Microbiol. 49, 147 (2009).
2. M. Rai, A. Yadav, and A. Gade, Biotechnol. Adv. 27, 76 (2009).
3. D. R. Monteiro, L. F. Gorup, A. S. Takamiya, A. C. Ruvollo-Filho, E. R. de Camargo, and D. B. Barbosa, Int. J. Antimicrob. Agents 34, 103 (2009).
4. H. H. Lara, E. N. Garza-Treviño, L. Ixtepan-Turrent, and D. K. Singh, J. Nanobiotechnol. 9, 30 (2011).
5. A. Nanda and M. Saravanan, Nanomedicine: NBM 5, 452 (2009).
6. A. M. Fayaz, K. Balaji, M. Girilal, R. Yadav, P. T. Kalaichelvan, and R. Venketesan, Nanomedicine: NBM 6, 103 (2009).
7. R. Bhattacharya and P. Mukherjee, Adv. Drug Deliver. Rev. 60, 1289 (2008).
8. J. Tian, K. K. Y. Wong, C. M. Ho, C. N. Lok, W. Y. Yu, C. M. Che, J. F. Chiu, and P. K. H. Tam, ChemMedChem 2, 129 (2007).
9. S. Galdiero, A. Falanga, M. Vitiello, M. Cantisani, V. Marra, and M. Galdiero, Molecules 16, 8894 (2011).
10. V. K. Sharma, R. A. Yngard, and Y. Lin, Adv. Colloid Interfac. 145, 83 (2009).
11. K. B. Narayanan and N. Sakthivel, Adv. Colloid Interfac. 169, 59 (2011).
12. D. Wei, W. Sun, W. Qian, Y. Ye, and X. Ma, Carbohyd. Res. 344, 2375 (2009).
13. X. Chen and A. Varki, ACS Chem. Biol. 5, 163 (2010).
14. H. Oka, T. Onaga, T. Koyama, C. T. Guo, Y. Suzuki, Y. Esumi, K. Hatano, D. Terunuma, and K. Matsuoka, Med. Chem. Lett. 18, 4405 (2008).
15. H. Oka, T. Onaga, T. Koyama, C. T. Guo, Y. Suzuki, Y. Esumi, K. Hatano, D. Terunuma, and K. Matsuoka, Bioorg. Med. Chem. Lett. 17, 5465 (2009).
16. A. Tsuchida, K. Kobayashi, N. Matsubara, T. Muramatsu, T. Suzuki, and Y. Suzuki, Glycoconjugate J. 15, 1047 (1998).
17. F. Feng, N. Miura, N. Isoda, Y. Sakoda, M. Okamatsu, H. Kida, and S. Nishimura, Bioorg. Med. Chem. Lett. 20, 3772 (2010).
18. S. M. Johansson, N. Arnberg, M. Elofsson, G. Wadell, and J. Kihlberg, ChemBioChem 6, 358 (2005).
19. I. Papp, C. Sieben, K. Ludwig, M. Roskamp, C. Böttcher, S. Schlecht, A. Herrmann, and R. Haag, Small 6, 2900 (2010).
20. M. M. Kemp, A. Kumar, S. Mousa, E. Dyskin, M. Yalcin, P. Ajayan, R. J. Linhardt, and S. A. Mousa, Nanotechnology 20, 455104 (2009).
21. Clinical and Laboratory Standards Institute. M100-S17, P. Wayne: CLSI (2007).
22. D. Wei and W Qian, Colloid. Surface. B 62, 136 (2008).
23. L. Jin and R. Bai, Langmuir 18, 9765 (2002).
24. M. Guzman, J. Dille, and S. Godet, Nanomedicine: NBM 8, 37 (2012).
25. J. R. Morones, J. L. Elechiguerra, A. Camacho, K. Holt, J. B. Kouri, J. T. Ramirez, and M. J. Yacaman, Nanotechnology 16, 2346 (2005).
26. G. A. Sotiriou and S. E. Pratsinis, Environ. Sci. Technol. 44, 5649 (2010).
27. S. Shrivastava, T. Bera, A. Roy, G. Singh, P. Ramachandrarao, and D. Dash, Nanotechnology 18, 225103 (2007).
28. N. Perez-Moral, C. Adnet, T. R. Noel, and R. Parker, Eur. J. Pharm. Biopharm. 78, 264 (2011).
29. S. Kamiya, T. Kurita, A. Miyagishima, and M. Arakawa, Drug Dev. Ind. Pharm. 35, 1022 (2009).
30. S. Yoshioka, T. Miyazaki, Y. Aso, and T. Kawanishi, Pharm. Res. 24, 1660 (2007).
31. L. L. Chang, D. Shepherd, J. Sun, D. Ouellette, K. L. Grant, X. C. Tang, and M. J. Pikal, J. Pharm. Sci. 94, 1427 (2005).
32. P. O. Souillac, C. R. Middaugh, and J. H. Rytting, Int. J. Pharm. 235, 207 (2002).
33. M. Holzer, V. Vogel, W. Mäntele, D. Schwartz, W. Haase, and K. Langer, Eur. J. Pharm. Biopharm. 72, 428 (2009).